PINEOBLASTOMA
Clinical trials for PINEOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new PINEOBLASTOMA trials appear
Sign up with your email to follow new studies for PINEOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with brain cancer: triple therapy trial launches
Disease control Recruiting nowThis early-phase trial tests a new drug (SGT-53) combined with radiation and immunotherapy (Nivolumab) in up to 18 children whose brain tumors have returned or not responded to standard treatments. The main goal is to find a safe dose and understand side effects. It is not a cure…
Matched conditions: PINEOBLASTOMA
Phase: EARLY_PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
Custom immune cells take aim at childhood brain cancers
Disease control Recruiting nowThis early-phase study tests a personalized treatment for children under 5 with certain brain tumors. Doctors take a patient's own immune cells, train them to recognize unique markers from their tumor, and give them back to fight the cancer. The goal is to see if this approach is…
Matched conditions: PINEOBLASTOMA
Phase: PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
New hope for toddlers with rare brain cancers: targeted chemo trial launches
Disease control Recruiting nowThis early-phase study tests whether adding a chemotherapy drug (topotecan) given directly into the spinal fluid, followed by maintenance chemo, is safe and feasible for children under 6 with high-risk embryonal brain tumors. About 15 children will participate. The goal is to see…
Matched conditions: PINEOBLASTOMA
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated May 12, 2026 13:48 UTC
-
Engineered immune cells target deadly childhood brain tumors in first human trial
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and young adults with medulloblastoma or similar brain tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack…
Matched conditions: PINEOBLASTOMA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 04, 2026 16:31 UTC